These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 20577000)

  • 21. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
    Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
    Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course of concomitant Hbv and Hcv infection in renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Rancewicz Z; Rowińska D; Kozłowska-Boszko B; Wyzga J; Walewska-Zielecka B; Rowiński W; Szmidt J; Lao M
    Ann Transplant; 1996; 1(2):11-2. PubMed ID: 9869922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing HBV in patients with impaired immunity.
    Wursthorn K; Wedemeyer H; Manns MP
    Gut; 2010 Oct; 59(10):1430-45. PubMed ID: 20525968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
    Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
    Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.
    Markovic S; Drozina G; Vovk M; Fidler-Jenko M
    Hepatogastroenterology; 1999; 46(29):2925-30. PubMed ID: 10576374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.
    López-Serrano P; Pérez-Calle JL; Sánchez-Tembleque MD
    World J Gastroenterol; 2013 Mar; 19(9):1342-8. PubMed ID: 23538480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C Virus Infection Is Positively Associated with Gallstones in Liver Cirrhosis.
    Zhang FM; Chen LH; Chen HT; Shan GD; Hu FL; Yang M; Chen WG; Xu GQ
    Digestion; 2016; 93(3):221-8. PubMed ID: 27093174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
    Juan J; Feld JJ
    Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease.
    Lee JM; Wei SC; Lee KM; Ye BD; Mao R; Kim HS; Park SJ; Park SH; Oh EH; Im JP; Jang BI; Kim DB; Takeuchi K
    Gut Liver; 2022 May; 16(3):396-403. PubMed ID: 34593670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy.
    Saitta C; Pontisso P; Brunetto MR; Fargion S; Gaeta GB; Niro GA; Picciotto A; Smedile A; Squadrito G; Raimondo G
    Antivir Ther; 2006; 11(7):931-4. PubMed ID: 17302256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease.
    Morisco F; Castiglione F; Rispo A; Stroffolini T; Vitale R; Sansone S; Granata R; Orlando A; Marmo R; Riegler G; Vecchi M; Biancone L; Caporaso N
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S40-8. PubMed ID: 21195371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China.
    Chen D; Luo S; Ben Q; Lu L; Wan X; Wu J
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):509-515. PubMed ID: 28350740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.
    Chiu HY; Chen CH; Wu MS; Cheng YP; Tsai TF
    Br J Dermatol; 2013 Dec; 169(6):1295-303. PubMed ID: 23746170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic dysfunction in children with acute lymphoblastic leukemia in remission: relation to hepatitis infection.
    Meir H; Balawi I; Nayel H; El Karaksy H; El Haddad A
    Med Pediatr Oncol; 2001 Apr; 36(4):469-73. PubMed ID: 11260570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.
    Coppola N; Pisapia R; Tonziello G; Martini S; Imparato M; Piai G; Stanzione M; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
    Antivir Ther; 2008; 13(2):307-18. PubMed ID: 18505182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.
    Salpini R; Colagrossi L; Bellocchi MC; Surdo M; Becker C; Alteri C; Aragri M; Ricciardi A; Armenia D; Pollicita M; Di Santo F; Carioti L; Louzoun Y; Mastroianni CM; Lichtner M; Paoloni M; Esposito M; D'Amore C; Marrone A; Marignani M; Sarrecchia C; Sarmati L; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V
    Hepatology; 2015 Mar; 61(3):823-33. PubMed ID: 25418031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.